• 1
    Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635643.
  • 2
    Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 26832693.
  • 3
    Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908913.
  • 4
    Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992.
  • 5
    Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 16231630.
  • 6
    Aylwin S. Gastrointestinal surgery and gut hormones. Curr Opin Endocrinol Diabetes 2005; 12: 8998.
  • 7
    Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404: 661671.
  • 8
    Schwartz MW, Morton GJ. Obesity: keeping hunger at bay. Nature 2002; 418: 595597.
  • 9
    Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL et al. Gut hormone PYY3–36 physiologically inhibits food intake. Nature 2002; 418: 650654.
  • 10
    Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS et al. Inhibition of food intake in obese subjects by peptide YY3–36. N Engl J Med 2003; 349: 941948.
  • 11
    Korner J, Bessler M, Cirilo L, Conwell IM, Daud A, Restuccia NL et al. Effects of Roux-en-equation image gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY and insulin. J Clin Endocrinol Metab 2005; 90: 359365.
  • 12
    Le Roux CW, Aylwin SJB, Batterham RL, Borg CM, Coyle F, Prasad V et al. Gut hormone profiles following bariatric surgery favour an anorectic state, facilitate weight loss and improved metabolic parameters. Ann Surg 2006; 243:in press.
  • 13
    Drucker DJ. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol 2003; 17: 161171.
  • 14
    Kreymann B, Williams G, Ghatei MA, Bloom SR. Glucagon-like peptide-1 7–36: a physiological incretin in man. Lancet 1987; ii: 13001304.
  • 15
    Gutzwiller JP, Drewe J, Goke B, Schmidt H, Rohrer B, Lareida J et al. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol 1999; 276: R1541R1544.
  • 16
    Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H et al. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 2003; 144: 51495158.
  • 17
    Clements RH, Gonzalez QH, Long CI, Wittert G, Laws HL. Hormonal changes after Roux-en equation image gastric bypass for morbid obesity and the control of type-II diabetes mellitus. Am Surg 2004; 70: 14.
  • 18
    Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339350.
  • 19
    Olbers T, Lonroth H, Fagevik-Olsen M, Lundell L. Laparoscopic gastric bypass: development of technique, respiratory function, and long-term outcome. Obes Surg 2003; 13: 364370.
  • 20
    Savage AP, Adrian TE, Carolan G, Chatterjee VK, Bloom SR. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 1987; 28: 166170.
  • 21
    English PJ, Ghatei MA, Malik IA, Bloom SR, Wilding JP. Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab 2002; 87: 2984.
  • 22
    Ghatei MA, Uttenthal LO, Bryant MG, Christofides ND, Moody AJ, Bloom SR. Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas. Endocrinology 1983; 112: 917923.
  • 23
    Naslund E, Melin I, Gryback P, Hagg A, Hellstrom PM, Jacobsson H et al. Reduced food intake after jejunoileal bypass: a possible association with prolonged gastric emptying and altered gut hormone patterns. Am J Clin Nutr 1997; 66: 2632.
  • 24
    Kenler HA, Brolin RE, Cody RP. Changes in eating behavior after horizontal gastroplasty and Roux-en-equation image gastric bypass. Am J Clin Nutr 1990; 52: 8792.
  • 25
    Adrian TE, Savage AP, Fuessl HS, Wolfe K, Besterman HS, Bloom SR. Release of peptide YY (PYY) after resection of small bowel, colon, or pancreas in man. Surgery 1987; 101: 715719.
  • 26
    Adrian TE, Savage AP, Bacarese-Hamilton AJ, Wolfe K, Besterman HS, Bloom SR. Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology 1986; 90: 379384.
  • 27
    Imamura M. Effects of surgical manipulation of the intestine on peptide YY and its physiology. Peptides 2002; 23: 403407.
  • 28
    Mason EE. Ileal [correction of ilial] transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg 1999; 9: 223228.
  • 29
    Naslund E, Gryback P, Hellstrom PM, Jacobsson H, Holst JJ, Theodorsson E et al. Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. Int J Obes Relat Metab Disord 1997; 21: 387392.
  • 30
    Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 2003; 52: 10981103.
  • 31
    Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G et al. Effect of laparoscopic Roux-en equation image gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467484.
  • 32
    Rubino F, Marescaux J. Effect of duodenal–jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004; 239: 111.
  • 33
    Baskin DG, Figlewicz Latteman D, Seeley RJ, Woods SC, Porte D Jr, Schwartz MW. Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res 1999; 848: 114123.
  • 34
    Faraj M, Havel PJ, Phelis S, Blank D, Sniderman AD, Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003; 88: 15941602.
  • 35
    Hanusch-Enserer U, Brabant G, Roden M. Ghrelin concentrations in morbidly obese patients after adjustable gastric banding. N Engl J Med 2003; 348: 21592160.
  • 36
    Holdstock C, Ludvigsson J, Karlsson FA. Abnormal ghrelin secretion in new onset childhood type 1 diabetes. Diabetologia 2004; 47: 150151.